Gastric cancer chemoprevention:hopes and challenges of aspirin,metformin,and other classic drugsLI Songbo, SHI Yongquan781-789
PLEK2 as a promising pan-cancer biomarker:insights from its expression profileZHANG Yuanci, PANG Maogui, MIAO Ge, WANG Haojia, DU Shuya, WANG Junshu, HUANG Xiaoyu, JI Songtao, SUN Jingjing, LU Yuanyuan, ZHAO Xiaodi, WANG Xin790-798
Role and mechanism of eEF1A1 in metastasis of colorectal cancerWANG Chen, FAN Ahui, GUO Xingxian, MIAO Ge, ZHANG Yuanci, CAO Tianyu, WANG Xin, ZHAO Xiaodi799-804,811
Preparation and characterization of a rabbit anti-mouse CD300e polyclonal antibody and its tissue localization in a mouse liver regeneration modelWANG Shuai, YANG Tao, WANG Dan, LIANG Defeng, CAO Yanlong, ZHUANG Ran, YIN Jikai805-811
Metabolites mediate immune cells to participate in the occurrence of non-alcoholic fatty liver disease:a multivariate Mendelian randomization analysisDAI Hongyuan, QIAN Zhenwei, LU Yinying, HAN Juqiang812-818
GPNMB as a diagnostic and predictive biomarker for metabolic dysfunction-associated steatotic liver disease and steatohepatitisCHEN Chen, XU Hao, DU Wei, LIU Jingjing, WANG Lin819-826
Efficacy and safety of Saccharomyces boulardii as adjunctive therapy in rescue treatment for Helicobacter pylori infection:a systematic reviewLIU Yuhao, ZHU Xiaojing, ZHANG Ju, LI Jie, LI Denghua, ZHANG Yanpeng, GUO Qiqi, SHI Yongquan827-834
Tegoprazan combined with minocycline dual therapy versus bismuth-containing quadruple therapy for Helicobacter pylori eradication:a randomized controlled trialZHANG Ju, LI Jie, LI Denghua, ZHU Xiaojing, GUO Qiqi, LIU Yuhao, ZHANG Yanpeng, SHI Yongquan835-840
Research progress and trend analysis of licorice in the treatment of liver injury based on CiteSpace knowledge mapCHEN Yingnan, FAN Wenbing, SONG Chengwu841-847
Transcriptomic study on the effects of subculture under simulated microgravity on the biological characteristics of mesenchymal stem cellsXUE Tong, HONG Dexuan, XIE Xuan, GUO Xian, ZHANG Shu, MA Ke, HU Zebing848-856